320 related articles for article (PubMed ID: 17896899)
1. Pulmonary sarcoidosis associated with etanercept therapy.
Farah RE; Shay MD
Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
[TBL] [Abstract][Full Text] [Related]
2. Parapharyngeal abscess in a patient receiving etanercept.
Borrás-Blasco J; Nuñez-Cornejo C; Gracia-Perez A; Rosique-Robles JD; Casterá MD; Viosca E; Abad FJ
Ann Pharmacother; 2007 Feb; 41(2):341-4. PubMed ID: 17227824
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
de Vlam K; Lories RJ
Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
6. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
7. Optic neuritis with concurrent etanercept and isoniazid therapy.
Noguera-Pons R; Borrás-Blasco J; Romero-Crespo I; Antón-Torres R; Navarro-Ruiz A; González-Ferrandez JA
Ann Pharmacother; 2005 Dec; 39(12):2131-5. PubMed ID: 16264061
[TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experience with etanercept in the treatment of psoriasis].
Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
[TBL] [Abstract][Full Text] [Related]
10. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary sarcoidosis developing during treatment with etanercept].
Kerjouan M; Jouneau S; Lena H; Luraine R; Desrues B; Delaval P
Rev Mal Respir; 2011 Mar; 28(3):360-4. PubMed ID: 21482342
[TBL] [Abstract][Full Text] [Related]
12. Subacute annular generalized pustular psoriasis treated with etanercept and cyclosporine combination.
Ricotti C; Kerdel FA
J Drugs Dermatol; 2007 Jul; 6(7):738-40. PubMed ID: 17763600
[TBL] [Abstract][Full Text] [Related]
13. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
[TBL] [Abstract][Full Text] [Related]
14. Onset of lichen planus during treatment with etanercept.
Musumeci ML; Lacarrubba F; Micali G
Am J Clin Dermatol; 2010; 11 Suppl 1():55-6. PubMed ID: 20586513
[TBL] [Abstract][Full Text] [Related]
15. Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study.
Gottlieb AB; Kircik L; Eisen D; Jackson JM; Boh EE; Strober BE; Frankel E; Xia HA; Stevens SR
J Dermatolog Treat; 2006; 17(6):343-52. PubMed ID: 17853307
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of pemphigus vulgaris with etanercept in four patients.
Shetty A; Marcum CB; Glass LF; Carter JD
J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
[TBL] [Abstract][Full Text] [Related]
17. The medical uses and side effects of etanercept with a focus on cutaneous disease.
Scheinfeld N
J Drugs Dermatol; 2004; 3(6):653-9. PubMed ID: 15624748
[TBL] [Abstract][Full Text] [Related]
18. The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case report.
Lamazza L; Guerra F; Pezza M; Messina AM; Galluccio A; Spink M; De Biase A
Aust Dent J; 2009 Jun; 54(2):161-5. PubMed ID: 19473159
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.
Berman B; Patel JK; Perez OA; Viera MH; Amini S; Block S; Zell D; Tadicherla S; Villa A; Ramirez C; De Araujo T
J Drugs Dermatol; 2008 Aug; 7(8):757-61. PubMed ID: 18720692
[TBL] [Abstract][Full Text] [Related]
20. High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.
De Felice C; Mazzotta A; Esposito M; Bianchi L; Chimenti S
J Dermatolog Treat; 2006; 17(6):355-8. PubMed ID: 17853309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
